[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-344677-105":3,"detail-sidebar-cat-0-en-105":85,"doc-detail-344677-en":135},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":78,"head_meta":80,"extra_data":82,"updated_unix":84},105,"en","metformin-treatment-and-reduction-of-gastrointestinal-cancer-risk-a-2-sample-mendelian-randomization-study","Metformin treatment and reduction of gastrointestinal cancer risk - A 2-sample Mendelian randomization study","","This observational study evaluates the causal relationship between metformin treatment and the prevention of multiple gastrointestinal and other cancer types using a 2-sample Mendelian randomization (MR) framework. Genome-wide association study summary data were leveraged to test associations between metformin exposure and various cancers, and to examine potential causal effects of metformin-related targets, including AMPK, mitochondrial complex I, mitochondrial glycerol 3-phosphate dehydrogenase, and GDF15. Estimates were obtained using IVW, MR-Egger, weighted median, and Wald ratio methods, with robustness checked in R via the TwoSampleMR package. IVW suggested protective effects against esophageal, gastric, and colorectal cancers, while Wald ratio identified a significant causal link between GDF15 and colorectal cancer.",{"@graph":14,"@context":77},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/metformin-treatment-and-reduction-of-gastrointestinal-cancer-risk-a-2-sample-mendelian-randomization-study/344677/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/metformin-treatment-and-reduction-of-gastrointestinal-cancer-risk-a-2-sample-mendelian-randomization-study/344677.png","ImageObject",300,407,{"name":42,"@type":43},"Himbo","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-18","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",15,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69,73],{"name":60,"@type":61,"acceptedAnswer":62},"What was the primary aim of the study?","Question",{"text":63,"@type":64},"To assess whether metformin treatment causally reduces the risk of various cancer types using a 2-sample Mendelian randomization analysis.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"Which metformin-related targets were investigated in addition to metformin exposure?",{"text":68,"@type":64},"The study examined causal effects of AMPK, mitochondrial complex I, mitochondrial glycerol 3-phosphate dehydrogenase, and GDF15.",{"name":70,"@type":61,"acceptedAnswer":71},"What did the inverse-variance weighting analysis show?",{"text":72,"@type":64},"It suggested a protective effect of metformin against esophageal, gastric, and colorectal cancers, with all reported odds ratios \u003C 0.1 and P \u003C 0.05.",{"name":74,"@type":61,"acceptedAnswer":75},"How did the study connect GDF15 to colorectal cancer?",{"text":76,"@type":64},"Wald ratio analysis found a significant causal association between GDF15 and colorectal cancer, and the results suggest the protective effect of metformin on colorectal cancer may be partially mediated by GDF15.","https://schema.org",{"og:url":32,"og:type":79,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":81,"canonical":32},"index,follow",{"doc_id":83,"site_id":7},344677,1790633993,{"code":4,"msg":86,"data":87},"success",[88,92,96,100,105,110,115,119,124,127,131],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":97,"show_sort_weight":98,"slug":99},"Exam",70,"exam",{"id":101,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},5,"Comic",60,"comic",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},6,"Technology",50,"technology",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":112,"show_sort_weight":113,"slug":114},7,"Healthcare",40,"healthcare",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":117,"slug":118},8,30,"research-report",{"id":120,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":122,"slug":123},9,"Religion & Spirituality",20,"religion-spirituality",{"id":122,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":122,"slug":126},"World Cup","world-cup",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":128,"slug":130},10,"Lifestyle","lifestyle",{"id":132,"doc_module":4,"doc_module_name":25,"category_name":133,"show_sort_weight":101,"slug":134},19,"General","general",{"code":4,"msg":86,"data":136},{"doc_id":83,"user_id":137,"nickname":42,"user_avatar":138,"doc_module":4,"category_id":116,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":139,"file_id":140,"file_url":141,"file_type":142,"file_size":143,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":111,"language":144,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":145,"faqs":146,"seo_title":147,"seo_description":12,"update_tm":148,"read_time":149,"preview_page_count":33,"preview_urls":150},687197100911,"https://ap-avatar.wpscdn.com/avatar/a000239b6f1da00475?x-image-process=image/resize,m_fixed,w_180,h_180&k=1785132997149421697","®  \n Observational Study   \nMetformin treatment and reduction of gastrointestinal cancer risk  \nA 2-sample Mendelian randomization study  \nDongcun Huang, MDa , Fujun Zhang, MDa , Tao Huang, MDa ,*  \n\n| Abstract\u003Cbr>This study aimed to examine the causal relationship between metformin treatment and the prevention of various cancer types through a 2-sample Mendelian randomization (MR) analysis. Utilizing genome-wide association study summary data, a 2-sample MR approach was employed to assess the association between metformin treatment and multiple cancer types. The analysis further investigated the causal effects of specific metformin targets, including adenosine monophosphate-activated protein kinase (AMPK), mitochondrial complex I, mitochondrial glycerol 3-phosphate dehydrogenase, and growth differentiation factor 15 (GDF15) . Causal associations were evaluated using inverse-variance weighting, MR-Egger, weighted median, and Wald ratio methods. Sensitivity analyses were performed using the TwoSampleMR package in R to ensure robustness. inverse-variance weighting estimates demonstrated a protective effect of metformin against esophageal, gastric, and colorectal cancers (all odds ratios \u003C0 . 1, all P \u003C .05) . The Wald ratio analysis identified a significant causal association between GDF15 and colorectal cancer (odds ratios: 0.927, 95% confidence interval: 0.883–0.974, P = .003) . However, no significant causal relationships were observed between the other metformin targets and the aforementioned cancers. All single-nucleotide polymorphisms used as instrumental variables exhibited strong associations, and no evidence of horizontal pleiotropy was detected. The findings provide genetic evidence supporting a potential protective role of metformin against the development of esophageal, gastric, and colorectal cancers. Furthermore, our analysis suggests that the protective effect of metformin on colorectal cancer might be partially mediated by GDF15, which warrants further investigation. |\n| --- |\n| Abbreviations: AMPK = AMP-activated protein kinase, CI = confidence interval , GDF15 = growth differentiation factor 15 , GWAS = genome-wide association study, HCC = hepatocellular carcinoma, HR = hazard ratio, IVW = inverse-variance weighting, MCI = mitochondrial complex 1, MG3 = mitochondrial glycerol 3, Mnk-erp = malignant neoplasm of kidney, except renal pelvis, MR = Mendelian randomization, OR = odds ratio, SNPs = single-nucleotide polymorphisms, T2DM = type 2 diabetes mellitus. |\n| Keywords: colorectal cancer, gastrointestinal cancer, Mendelian randomization, pan-cancer |\n\n1. Background  \nCancer represents a growing global health challenge, with projections indicating it will surpass ischemic heart disease as the primary cause of mortality by 2060.[1] This malignancy has emerged as the most significant barrier to enhancing life expectancy in the 21st century, prompting substantial research focus on cancer prevention and therapeutic strategies. Among pharmacological interventions, statins, metformin, and  \nbisphosphonates have been identified as the most promising agents for cancer chemoprevention.[2] Metformin, a derivative of French lilac and the first-line therapeutic agent for type 2 diabetes mellitus has attracted considerable attention as a potential cancer preventive medication due to its cost-effectiveness and favorable safety profile.[3]  \nThe investigation of metformin’s role in cancer prevention originated from a seminal 2005 study demonstrating its potential to reduce cancer risk.[4] Over the subsequent 18 years,  \nThis work was supported by research grants from the National Natural Science Foundation of P.R. China (No. 82472082). The sponsors had no role in the study design; the collection, analysis, or interpretation of the data; or the decision to submit the article for publication.  \nThe authors have no conflicts of interest to disclose.  \nAll data generated or analyzed during this study are included in this published","cbCaiaAdn8U5aCnB","https://ap.wps.com/l/cbCaiaAdn8U5aCnB","pdf",675818,"English","# Abstract\n# Abbreviations\n# Background\n## Global burden and cancer prevention context\n## Metformin as a candidate chemopreventive agent","[{\"question\":\"What was the primary aim of the study?\",\"answer\":\"To assess whether metformin treatment causally reduces the risk of various cancer types using a 2-sample Mendelian randomization analysis.\"},{\"question\":\"Which metformin-related targets were investigated in addition to metformin exposure?\",\"answer\":\"The study examined causal effects of AMPK, mitochondrial complex I, mitochondrial glycerol 3-phosphate dehydrogenase, and GDF15.\"},{\"question\":\"What did the inverse-variance weighting analysis show?\",\"answer\":\"It suggested a protective effect of metformin against esophageal, gastric, and colorectal cancers, with all reported odds ratios \\u003c 0.1 and P \\u003c 0.05.\"},{\"question\":\"How did the study connect GDF15 to colorectal cancer?\",\"answer\":\"Wald ratio analysis found a significant causal association between GDF15 and colorectal cancer, and the results suggest the protective effect of metformin on colorectal cancer may be partially mediated by GDF15.\"}]","Metformin treatment and reduction of gastrointestinal cancer risk - A 2-sample Mendelian randomization study | PDF",1790054864,18,[151,155,159,163],{"page_no":22,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f014b570828de90c7e6f352a57d9221c.webp",983,1310,{"page_no":26,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b218418be3443412f52bf499882d1f69.webp",982,1309,{"page_no":30,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/91fbb05662d887bf93b1abc213449cc1.webp",981,1308,{"page_no":33,"url":164,"width":165,"height":166},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e911ea7c9cd3859066ffb937318ab10a.webp",980,1306]